Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Low-Dose CDK4/6 Inhibitors Induce Presentation of Pathway... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Low-Dose CDK4/6 Inhibitors Induce Presentation of Pathway Specific MHC ligands as Targets for Cancer Immunotherapy
0
Authors
Angel Charles
8 more
Angel Charles
•
Christopher Bourne
6 more
•
David Scheinberg
Published
June 19, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Cancer Oncology
Immunology
Genetics
Show all topics
DOI
10.1101/2020.06.18.157800
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Biochemistry
Cancer Oncology
Immunology
Genetics
Show all topics
DOI
10.1101/2020.06.18.157800
License
CC-BY
Other Formats
PDF
